Articles

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France
Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France;Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France
Cardarelli Hospital, Napoli, Italy
Hospital Universitario La Fe, University of Valencia, Spain
First Affiliated Hospital of Soochow University, Suzhou, China
Hospital Reina Sofia, Córdoba, Spain
Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France
Azienda Ospedaliera, Reggio Calabria, Italy
Hospital Sao Joao and School of Medicine, Porto, Portugal
Hospital dos Capuchos, Lisboa, Portugal
Hospital San Martino, Genova, Italy
Centre Paoli Calmettes, Marseille, France
Rome Transplant Network, Rome, Italy
Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
Churchill Hospital, Oxford University, UK
Acute Leukemia Working Party -EBMT, Hôpital Saint Antoine, AP-HP, Université Pierre et Marie Curie Paris 6 UPMC, INSERM UMR-S 938, Paris, France;Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris, France
Vol. 99 No. 8 (2014): August, 2014 https://doi.org/10.3324/haematol.2014.105197